GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyfuse Biomedical KK (TSE:4892) » Definitions » FCF Margin %

Cyfuse Biomedical KK (TSE:4892) FCF Margin % : 0.00% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cyfuse Biomedical KK FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cyfuse Biomedical KK's Free Cash Flow for the three months ended in Dec. 2023 was 円0.00 Mil. Cyfuse Biomedical KK's Revenue for the three months ended in Dec. 2023 was 円31.38 Mil. Therefore, Cyfuse Biomedical KK's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Cyfuse Biomedical KK's current FCF Yield % is -10.24%.

The historical rank and industry rank for Cyfuse Biomedical KK's FCF Margin % or its related term are showing as below:

TSE:4892' s FCF Margin % Range Over the Past 10 Years
Min: -951.97   Med: -191.39   Max: 22.81
Current: -951.97


During the past 4 years, the highest FCF Margin % of Cyfuse Biomedical KK was 22.81%. The lowest was -951.97%. And the median was -191.39%.

TSE:4892's FCF Margin % is ranked worse than
96.01% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.25 vs TSE:4892: -951.97


Cyfuse Biomedical KK FCF Margin % Historical Data

The historical data trend for Cyfuse Biomedical KK's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyfuse Biomedical KK FCF Margin % Chart

Cyfuse Biomedical KK Annual Data
Trend Dec20 Dec21 Dec22 Dec23
FCF Margin %
-214.04 22.81 -168.73 -951.97

Cyfuse Biomedical KK Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Cyfuse Biomedical KK's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cyfuse Biomedical KK's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyfuse Biomedical KK's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cyfuse Biomedical KK's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cyfuse Biomedical KK's FCF Margin % falls into.



Cyfuse Biomedical KK FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cyfuse Biomedical KK's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-581.77/61.112
=-951.97 %

Cyfuse Biomedical KK's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=0/31.383
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cyfuse Biomedical KK FCF Margin % Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyfuse Biomedical KK (TSE:4892) Business Description

Traded in Other Exchanges
N/A
Address
3-5-27, Mita, West Wing-1st Floor. Sumitomo Fudosan Mita Twin Building, Minato-ku, Tokyo, JPN
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Cyfuse Biomedical KK (TSE:4892) Headlines

No Headlines